Search research articles
Contact Us
Filters
Showing results (121-130 of 155) with videos related to
Page
of 16
Sort By:
American Journal of Hematology
|
March 28, 2026
Thirty Years of Classical Hematology Drugs in the US: Approvals, Costs, and Sales
Lucas T Go, Lewis T Go, Michelle A Elliott, et al.
European Journal of Haematology
|
December 1, 2020
Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide
Yi L Hwa, Martha Q Lacy, Morie A Gertz, et al.
Blood Advances
|
August 12, 2025
Assessment of Classical Hematologists and Classical Hematology Fellowship Programs at NCI-Designated Cancer Centers
Lewis T Go, Lucas T Go, Madugodaralalage Dsk Gunaratne, et al.
Leukemia
|
February 24, 2021
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients
Alissa Visram, Iuliana Vaxman, Abdullah S Al Saleh, et al.
American Journal of Hematology
|
November 25, 2021
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients
Patrick W Mellors, Taxiarchis Kourelis, Ronald S Go, et al.
Research Square
|
April 17, 2026
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure
Angela Dispenzieri, Maximilian Steinhardt, Eli Muchtar, et al.
Blood Neoplasia
|
June 2, 2025
Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis
Binoy Yohannan, Matthew Rees, Morie A Gertz, et al.
American Journal of Hematology
|
July 19, 2020
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio
Eli Muchtar, Morie A Gertz, Martha Q Lacy, et al.
Leukemia
|
October 27, 2021
Mortality trends in multiple myeloma after the introduction of novel therapies in the United States
Moritz Binder, Bharat Nandakumar, S Vincent Rajkumar, et al.
Blood Cancer Journal
|
January 3, 2026
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma
Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 155) with videos related to
Sort By:
Page
of 16
American Journal of Hematology
|
March 28, 2026
Thirty Years of Classical Hematology Drugs in the US: Approvals, Costs, and Sales
Lucas T Go, Lewis T Go, Michelle A Elliott, et al.
European Journal of Haematology
|
December 1, 2020
Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide
Yi L Hwa, Martha Q Lacy, Morie A Gertz, et al.
Blood Advances
|
August 12, 2025
Assessment of Classical Hematologists and Classical Hematology Fellowship Programs at NCI-Designated Cancer Centers
Lewis T Go, Lucas T Go, Madugodaralalage Dsk Gunaratne, et al.
Leukemia
|
February 24, 2021
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients
Alissa Visram, Iuliana Vaxman, Abdullah S Al Saleh, et al.
American Journal of Hematology
|
November 25, 2021
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients
Patrick W Mellors, Taxiarchis Kourelis, Ronald S Go, et al.
Research Square
|
April 17, 2026
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure
Angela Dispenzieri, Maximilian Steinhardt, Eli Muchtar, et al.
Blood Neoplasia
|
June 2, 2025
Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis
Binoy Yohannan, Matthew Rees, Morie A Gertz, et al.
American Journal of Hematology
|
July 19, 2020
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio
Eli Muchtar, Morie A Gertz, Martha Q Lacy, et al.
Leukemia
|
October 27, 2021
Mortality trends in multiple myeloma after the introduction of novel therapies in the United States
Moritz Binder, Bharat Nandakumar, S Vincent Rajkumar, et al.
Blood Cancer Journal
|
January 3, 2026
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma
Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
Page
of 16